Literature DB >> 12163420

Diabetic nephropathy: can renoprotection be extrapolated to cardiovascular protection?

Lionel H Opie, Hans-Henrik Parving.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12163420     DOI： 10.1161/01.cir.0000028099.24188.c4

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

Review 1.  The renin-angiotensin-aldosterone system as a target in coronary disease.

Authors:  James H O'Keefe; Jared T Lurk; Ravindra C Kahatapitiya; Janet A Haskin
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

2.  The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy.

Authors:  S Schäfer; W Linz; H Vollert; G Biemer-Daub; H Rütten; M Bleich; A E Busch
Journal:  Diabetologia       Date:  2003-11-14       Impact factor: 10.122

3.  Do inhibitors of the rennin-angiotensin system prevent chronic kidney disease?

Authors:  Brian Rayner
Journal:  Cardiovasc J Afr       Date:  2010 Jan-Feb       Impact factor: 1.167

4.  Screening for Nephropathy in Diabetes Mellitus: Is Micral-Test Valid among All Diabetics?

Authors:  Koubaa Afifa; Sriha Belguith Asma; Harzallah Nabil; Bellaleh Ahlem; Sahtout Mounira; Younes Kawthar; Triki Sonia; Hellara Ilhem; Neffati Fadoua; Najjar Fadhel; Soltani Mohamed
Journal:  Int J Chronic Dis       Date:  2016-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.